in

Juno Therapeutics CEO Hans Bishop Resigned

Longtime Juno Therapeutics CEO Hans Bishop leaves role after acquisition by Celgene

Hans Bishop, the co-founder and longtime CEO of immunotherapy company Juno Therapeutics, has quietly left that role following the company’s $9 billion acquisition by biotech giant Celgene, he told GeekWire on Tuesday. Bishop has also joined Celgene’s board of directors. Bishop helped found Juno when…


Name: Hans Bishop

Continent: North America

Country: USA

Company: Juno Therapeutics

Position: CEO

Reason: Resigned

Announcement Date: April 23, 2018, 10:00pm

Resignation Date: April 23, 2018, 10:00pm

Source 1: https://www.geekwire.com/2018/longtime-juno-therapeutics-ceo-hans-bishop-leaves-role-merger-celegene/


Add your submission

Image Video Audio Text Embed

This field is required

Drop Images Here

or

You don't have javascript enabled. Media upload is not possible.

Get image from URL

Maximum upload file size: 10 MB.

Processing...

This field is required

Drop Video Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://www.youtube.com/watch?v=WwoKkq685Hk

Add

Supported services:

Maximum upload file size: 20 MB.

Processing...

This field is required

Drop Audio Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://soundcloud.com/community/fellowship-wrapup

Add

Supported services:

Maximum upload file size: 150 MB.

Processing...

This field is required

e.g.: https://www.youtube.com/watch?v=DWYrcnehito

Supported services:

Processing...

Report

What do you think?

Leave a Reply